title: Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston University of Houston College of Pharmacy.
authors.forename: Truc T
authors.initials: TT
authors.lastname: Tran
authors.affiliation: Department of Pharmacy, Baylor St Luke's Medical Center, Houston, Texas.
authors.forename: Hannah R
authors.initials: HR
authors.lastname: Palmer
authors.affiliation: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
authors.forename: Marion R
authors.initials: MR
authors.lastname: Weimar
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston Universidad El Bosque, Bogotá, Colombia.
authors.forename: Cesar A
authors.initials: CA
authors.lastname: Arias
authors.affiliation: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Cook
authors.affiliation: University of Houston College of Pharmacy Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston.
authors.forename: Barbara E
authors.initials: BE
authors.lastname: Murray
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001414:Bacitracin / Q000008:administration & dosage* / Q000494:pharmacology; D016470:Bacteremia / Q000188:drug therapy*; D017576:Daptomycin / Q000494:pharmacology; D004318:Doxycycline / Q000008:administration & dosage; D041981:Gastrointestinal Tract / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D065507:Vancomycin-Resistant Enterococci / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D001414:Bacitracin; D004318:Doxycycline; D017576:Daptomycin